Why is Boston Bio falling/rising?

As of 23-Sep, Boston Bio Systems Ltd's stock price is currently at 7.95, reflecting an increase of 0.27 or 3.52%. The stock has shown a trend reversal, gaining after two consecutive days of decline. Additionally, it has outperformed its sector by 3.94% today. The stock's delivery volume has significantly increased by 207.14% compared to the 5-day average, indicating rising investor participation. Although the stock is trading higher than its 50-day and 100-day moving averages, it remains lower than the 5-day, 20-day, and 200-day moving averages. There are no positive or negative factors provided to further explain the stock's recent movement.
In the broader market context, the stock's performance over the past week shows a decline of 0.62%, while the Sensex has decreased by only 0.34%, indicating that Boston Bio has underperformed relative to the benchmark in the short term. Over the past month, the stock has also slightly declined by 0.13%, contrasting with the Sensex's gain of 0.98%. This suggests that while the stock is experiencing a short-term rise today, its recent performance has been weaker compared to the overall market.